USPTO serial 87734687
MX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- SIMCOX, KYLE DUNCAN
- Law office
- TMO LAW OFFICE 122 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with MX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
William L Montague, Jr.
WILLIAM L MONTAGUE, JR. MONTAGUE LAW PLLC163 E. MAIN ST.SUITE 300LEXINGTON, KY 40507Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Providing temporary use of on-line non-downloadable software for managing and verifying pharmaceutical drug prescriptions and associated data transactions utilizing blockchain-based platforms; Providing temporary use of on-line non-downloadable software for managing pharmaceutical drug prescriptions within an end-to-end network of prescription-prescribers and prescription-fillers; Providing temporary use of on-line non-downloadable software for the use of distributed ledger technology to control the prescription and fulfillment of controlled substance prescriptions; Providing temporary use of on-line non-downloadable software for controlling access to controlled substance prescriptions; Providing temporary use of on-line non-downloadable software for transferring and managing virtual tokens within the medical and pharmaceutical fields; Providing temporary use of on-line non-downloadable software for for accessing a distributed ledger data structure for use in the control of pharmaceutical drug prescriptions; Application service provider (ASP) featuring software for use managing and verifying pharmaceutical drug prescriptions and associated data transactions utilizing blockchain-based platforms; Application service provider (ASP) featuring software for use managing pharmaceutical drug prescriptions within an end-to-end network of prescription-prescribers and prescription-fillers; Application service provider (ASP) featuring software for use controlling access to controlled substance prescriptions; Application service provider (ASP) featuring software for use transferring and managing virtual tokens within the medical and pharmaceutical fields; Application service provider (ASP) featuring software for use the use of distributed ledger technology to control the prescription and fulfillment of controlled substance prescriptions; Application service provider (ASP) featuring software for use accessing a distributed ledger data structure for use in the control of pharmaceutical drug prescriptions; Software as a service (SAAS) services featuring software for managing and verifying pharmaceutical drug prescriptions and associated data transactions utilizing blockchain-based platforms; Software as a service (SAAS) services featuring software for managing pharmaceutical drug prescriptions within an end-to-end network of prescription-prescribers and prescription-fillers; Software as a service (SAAS) services featuring software for the use of distributed ledger technology to control the prescription and fulfillment of controlled substance prescriptions; Software as a service (SAAS) services featuring software for controlling access to controlled substance prescriptions; Software as a service (SAAS) services featuring software for transferring and managing virtual tokens within the medical and pharmaceutical fields; Software as a service (SAAS) services featuring software for accessing a distributed ledger data structure for use in the control of pharmaceutical drug prescriptions | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 4, 2019 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jan 4, 2019 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Apr 13, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 13, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 13, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 5, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 12, 2018 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jan 11, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 29, 2017 | NWAP | NEW APPLICATION ENTERED | — |